241 related articles for article (PubMed ID: 12869624)
1. Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons.
Zollner C; Shaqura MA; Bopaiah CP; Mousa S; Stein C; Schafer M
Mol Pharmacol; 2003 Aug; 64(2):202-10. PubMed ID: 12869624
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mu opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain.
Shaqura MA; Zöllner C; Mousa SA; Stein C; Schäfer M
J Pharmacol Exp Ther; 2004 Feb; 308(2):712-8. PubMed ID: 14593084
[TBL] [Abstract][Full Text] [Related]
3. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
[TBL] [Abstract][Full Text] [Related]
4. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
5. Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction.
Puehler W; Zöllner C; Brack A; Shaqura MA; Krause H; Schäfer M; Stein C
Neuroscience; 2004; 129(2):473-9. PubMed ID: 15501604
[TBL] [Abstract][Full Text] [Related]
6. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2004 Sep; 310(3):1020-6. PubMed ID: 15121763
[TBL] [Abstract][Full Text] [Related]
7. Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord.
Kohno T; Ji RR; Ito N; Allchorne AJ; Befort K; Karchewski LA; Woolf CJ
Pain; 2005 Sep; 117(1-2):77-87. PubMed ID: 16098668
[TBL] [Abstract][Full Text] [Related]
8. Functional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat.
Narita M; Miyoshi K; Narita M; Suzuki T
Neuroscience; 2007 Feb; 144(3):777-82. PubMed ID: 17156932
[TBL] [Abstract][Full Text] [Related]
9. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
10. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
Zhou L; Zhang Q; Stein C; Schäfer M
J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
[TBL] [Abstract][Full Text] [Related]
11. Expression and G-protein coupling of mu-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats.
Ballet S; Conrath M; Fischer J; Kaneko T; Hamon M; Cesselin F
Neuropeptides; 2003 Aug; 37(4):211-9. PubMed ID: 12906839
[TBL] [Abstract][Full Text] [Related]
12. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression.
Brack A; Rittner HL; Machelska H; Shaqura M; Mousa SA; Labuz D; Zöllner C; Schäfer M; Stein C
Pain; 2004 Mar; 108(1-2):67-75. PubMed ID: 15109509
[TBL] [Abstract][Full Text] [Related]
13. Colocalization of mu-opioid receptors and activated G-proteins in rat cingulate cortex.
Vogt LJ; Sim-Selley LJ; Childers SR; Wiley RG; Vogt BA
J Pharmacol Exp Ther; 2001 Dec; 299(3):840-8. PubMed ID: 11714867
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain.
Mousa SA; Cheppudira BP; Shaqura M; Fischer O; Hofmann J; Hellweg R; Schäfer M
Brain; 2007 Feb; 130(Pt 2):502-13. PubMed ID: 17142830
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
[TBL] [Abstract][Full Text] [Related]
16. Modulation by neuropeptide FF of the interaction of mu-opioid (MOP) receptor with G-proteins.
Kersanté F; Moulédous L; Zajac JM; Mollereau C
Neurochem Int; 2010; 56(6-7):768-73. PubMed ID: 20211672
[TBL] [Abstract][Full Text] [Related]
17. Chronic arthritis down-regulates peripheral mu-opioid receptor expression with concomitant loss of endomorphin 1 antinociception.
Li Z; Proud D; Zhang C; Wiehler S; McDougall JJ
Arthritis Rheum; 2005 Oct; 52(10):3210-9. PubMed ID: 16200625
[TBL] [Abstract][Full Text] [Related]
18. Diverse immunocytochemical expression of opioid receptors in electrophysiologically defined cells of rat dorsal root ganglia.
Rau KK; Caudle RM; Cooper BY; Johnson RD
J Chem Neuroanat; 2005 Jun; 29(4):255-64. PubMed ID: 15927787
[TBL] [Abstract][Full Text] [Related]
19. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
20. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain.
Saland LC; Abeyta A; Frausto S; Raymond-Stintz M; Hastings CM; Carta M; Valenzuela CF; Savage DD
Alcohol Clin Exp Res; 2004 Jan; 28(1):98-104. PubMed ID: 14745307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
